↓ Skip to main content

Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist

Overview of attention for article published in Frontiers in Psychiatry, January 2014
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Readers on

mendeley
174 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist
Published in
Frontiers in Psychiatry, January 2014
DOI 10.3389/fpsyt.2014.00002
Pubmed ID
Authors

Cristiane von Werne Baes, Camila Maria Severi Martins, Sandra Márcia de Carvalho Tofoli, Mário Francisco Juruena

Abstract

Background: Evidence indicates that early life stress (ELS) can induce persistent changes in the hypothalamic-pituitary-adrenal (HPA) axis to respond to stress in the adult life that leads to depression. These appear to be related to the impairment of HPA hormones through binding to glucocorticoid (GR) and mineralocorticoid receptors (MR). The aim of this study was to evaluate the impact of ELS in HPA axis response to challenges with GR and MR agonists in depressed patients. Methods: We included 30 subjects, 20 patients with current major depression (HAM-D21 ≥ 17). Patients were recruited into two groups according to ELS history assessed by the Childhood Trauma Questionnaire (CTQ). The cortisol measures in the saliva and plasma were evaluated after using (at 10:00 p.m.) placebo, fludrocortisone (MR agonist), or dexamethasone (GR agonist). Results: Depressed patients showed a significantly lower salivary cortisol upon waking after placebo compared with controls. Moreover, cortisol awakening responses (CAR) after MR agonist were found to be lower in depressed patients than in controls. With CTQ scores, HAM-D21, body mass index and CAR after placebo, GR agonist, MR agonist we found in a Linear Regression model that depressive patients with ELS (p = 0.028) show differences between placebo vs. MR agonist (R = 0.51; p < 0.05) but not after GR agonist; in depressive patients, without ELS the data show differences between placebo vs. MR agonist (R = 0.69; p < 0.05); but now as well placebo vs. GR agonist (R = 0.53; p < 0.05). Conclusion: Our findings indicate that MR activity is impaired in depressed patients compared with controls. Furthermore, in spite of the previous limitations described, in depressed patients with ELS, there was suppression by MR agonist, indicating that patients with ELS are sensitive to MR agonists. In contrast with depressed patients without ELS, we find suppression after both MR and GR agonist. These data suggested that in ELS an imbalance exists between MR and GR with MR dysfunction.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Turkey 1 <1%
Netherlands 1 <1%
Brazil 1 <1%
Chile 1 <1%
Mexico 1 <1%
New Zealand 1 <1%
Unknown 166 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 17%
Student > Ph. D. Student 25 14%
Student > Bachelor 25 14%
Student > Master 15 9%
Student > Doctoral Student 13 7%
Other 31 18%
Unknown 35 20%
Readers by discipline Count As %
Medicine and Dentistry 40 23%
Psychology 27 16%
Agricultural and Biological Sciences 23 13%
Neuroscience 16 9%
Nursing and Health Professions 7 4%
Other 16 9%
Unknown 45 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2018.
All research outputs
#17,710,421
of 22,741,406 outputs
Outputs from Frontiers in Psychiatry
#6,082
of 9,870 outputs
Outputs of similar age
#220,771
of 305,211 outputs
Outputs of similar age from Frontiers in Psychiatry
#21
of 28 outputs
Altmetric has tracked 22,741,406 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,870 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.